E2F3 and cancer: The other 13 out of the 42 predicted and tested markers (BCL2L1, BID, CCND1, CCND2, CCND3, CCNE1, CDK2, CDK4, CREB1, E2F3, FGFR1, STAT1, VEGFC) are implicated with various cancers including some aspects of colorectal or gastric, and although published evidence exists, it is less abundant.